Article PDF
Avoid common mistakes on your manuscript.
References
Gregory EC, MacDorman MF, Martin JA. Trends in fetal and perinatal mortality in the United States, 2006–2012. NCHS Data Brief. 2014;169:1–7.
Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, Levine GL, Goldmann DA, Jarvis WR. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005;24: 766–73.
Depani SJ, Ladhani S, Heath PT, Lamagni TL, Johnson AP, Pebody RG, et al. The contribution of infections to neonatal deaths in England and Wales. Pediatr Infect Dis J. 2011;30:345–7.
Chassin MR. Improving the quality of health care: what’s taking so long? Health Aff (Millwood). 2013;32:1761–5.
Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, et al. NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.
Clock SA, Ferng YH, Tabibi S, Alba L, Patel SJ, Jia H, et al. Colonization with antimicrobial-resistant gramnegative bacilli at neonatal intensive care unit discharge. J Pediatr Infect Dis Soc. 2016 Mar 28. pii: piw014. [Epub ahead of print]
Hutchinson JM, Patrick DM, Marra F, Ng H, Bowie WR, Heule L, et al. Measurement of antibiotic consumption: A practical guide to the use of the anatomical therapeutic chemical classification and defined daily dose system methodology in Canada. Can J Infect Dis. 2004;15:29–35.
Schulman J, Dimand RJ, Lee HC, Duenas GV, Bennett MV, Gould JB. Neonatal intensive care unit antibiotic use. Pediatrics. 2015;135:826–33.
Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol. 2012;36:431–6.
Nash C, Simmons E, Bhagat P, Bartlett A. Antimicrobial stewardship in the NICU: Lessons we’ve learned. Neo reviews. 2014;15:e116–e112.
Murki S, Jonnala S, Mohammed F, Reddy A. Restriction of cephalosporins and control of extended spectrum betalactamase producing gram negative bacteria in a neonatal intensive care unit. Indian Pediatr. 2010;47:785–8.
Stocker M, van Herk W, El Helou S, Dutta S, Fontana MS, Schuerman FABA, et al. NeoPInS Study Group. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017 Jul 12. pii: S0140-6736(17)31444-7. [Epub ahead of print]
Couto RC, Barbosa JA, edrosa TM, Biscione FM. Creactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis: an intervention study. Braz J Infect Dis. 2007;1:240–5.
Saini SS, Dutta S, Ray P, Narang A. Short course versus 7- day course of intravenous antibiotics for probable neonatal septicemia: A pilot, open-label, randomized controlled trial. Indian Pediatr. 2011;48:19–24.
Jinka DR, Gandra S, Alvarez-Uria G, Torre N, Tadepalli D, Nayakanti RR. Impact of antibiotic policy on antibiotic consumption in a neonatal intensive care unit in India. Indian Pediatr. 2017;54:739–41.
References
Avinash B, Dutta AK, Chacko A. Pediatric inflammatory bowel disease in South India. Indian Pediatr. 2009;46:639–40.
Sathiyasekaran M, Bavanandam S, Sankarnarayanan S, Mohan M, Geetha M, Wadhwa N, et al. A questionnaire survey of pediatric inflammatory bowel disease in India. Indian J Gastroenterol. 2014;33:543–9.
Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, et al. Pediatric IBDunclassified is less common than previously reported; Results of an 8-year audit of the EUROKIDS Registry. Inflamm Bowel Dis. 2015;21:2145–53.
Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD- a metaanalysis. J Crohns Colitis. 2009;3:277–81.
Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.
Aloi M, Birimberg-Schwartz L, Buderus S, Hojsak I, Fell JM, Bronsky J, et al. Treatment options and outcomes of pediatric IBDU compared with other IBD subtypes: A retrospective multicenter study from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis. 2016;22:1378–83.
Malaty HM, Mehta S, Abraham B, Garnett EA, Ferry GD. The natural course of inflammatory bowel diseaseindeterminate from childhood to adulthood: within a 25 year period. Clin Exp Gastroenterol. 2013;23:115–21.
Notteghem B, Salomez JL, Gower-Rousseau C, Marti R, Lemahieu M, Nuttens MC, et al. What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in Norther-Pas-de-Calais region. Gastroenterol Clin Biol. 1993;17:811–5.
Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58: 795–806.
Paul SP, Sandhu BK. Long-term outcome of inflammatory bowel disease–unclassified in children. Indian Pediatr. 2017;54:742–5.
Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, et al. Natural history of pediatric inflammatory bowel diseases over a 5-year follow-up: A retrospective review of data from the register of pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2008;46: 539–45.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murki, S., Kishore, S.S., Poddar, U. et al. Editorial. Indian Pediatr 54, 723–727 (2017). https://doi.org/10.1007/s13312-017-1162-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-017-1162-7